孟鲁司特钠治疗小儿咳嗽变异性哮喘的运用效果分析

打开文本图片集
摘 要: 目的 探究对小儿咳嗽变异性哮喘患儿,应用孟鲁司特钠治疗取得的效果分析。方法 选择时间为2022年8月—2023年8月,小儿咳嗽变异性哮喘患者80例,观察组(孟鲁司特钠、布地奈德联合);对照组(单用布地奈德治疗),各40例。比较分析肺功能指标评分、疾病疗效、不良反应等。结果 观察组治疗后的FEV1/FVC和FEV1较对照组更高(P
关键词: 小儿咳嗽变异性哮喘 孟鲁司特钠 布地奈德 疗效评估 不良反应
中图分类号: R720文献标识码: A文章编号: 1679-3567(2024)03-0080-03
Analysis of the Efficacy of Montelukast Sodium in the Treatment of Cough-Variant Asthma in Children
LI Meiyi
Changchun Medical College, Changchun, Jilin Province, 130031 China
Abstract: Objective To explore an analysis of the effects of montelukast sodium in the treatment of children with pediatric cough-variant asthma. Methods A total of 80 children with pediatric cough-variant asthma from August 2022 to August 2023 were selected, with 40 cases in the observation group (the combination of montelukast sodium and budesonide) and the control group (treated with budesonide alone) each, and the scores of lung function indexes, disease efficacy and adverse reactions were compared and analyzed. Results After treatment, the FEV1/FVC and FEV1 of the observation group were higher than those of the control group (P
Key Words: Cough variant asthma in children; Montelukast sodium; Budesonide; Efficacy assessment; Adverse reaction
小儿咳嗽变异性哮喘(Cough Variant Asthma,CVA)的出现同其自身抵抗力差密切关联,常年来发病率居高不下,症状表现为顽固性、阵发性咳嗽,严重影响到患者的健康成长和生活质量,亟须开展积极治疗[1]。(剩余3767字)